Please Wait
Applying Filters...
menu
    • menu

    List of Drug Master Files (DMF) of Altretamine [USAN:INN:BAN] Active Pharmaceutical Ingredient (API) submitted to the U.S. FDA. Original Data : FDA Website

    Client Email Product
    US, Europe turn to advanced manufacturing, stockpiling to strengthen drug supply chains

    Data Compilation
    #PharmaFlow

    Pipeline Prospector Sept 2024: BMS wins landmark FDA approval for schizophrenia med; Sanofi’s Dupixent okayed for COPD

    Stock Recap
    #PipelineProspector

    Menu

    Altretamine [USAN:INN:BAN]

    ACTIVE PHARMA INGREDIENTS

    FINISHED DOSAGE FORMULATIONS

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    DIGITAL CONTENT

    REF. STANDARDS & IMPURITIES

    PharmaCompass
    Xls download

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow
    ListList of Suppliers
    refreshReset Filter
    refresh Reset Filter
    Price Info Price Info
    product-page Product Main Page

    Data in the table can be downloaded after upgrading. In the meantime, you can access the data through the menu.

    Last Updated on PharmaCompass Virtual Booth Country Holder DMF No. Subject Submission Date Status Type GDUFA DMF Review GDUFA Review Date GDUFA Payment Date
    26/09/2024 CHEMSYN CHEMICAL CORPORATION
    Canada
    		 CHEMSYN SCIENCE LABORATORIES 9703 ALTRETAMINE 1992-05-29 Inactive II N/A
    26/09/2024 F. Hoffmann-La Roche
    Switzerland
    		 KV PHARMACEUTICAL CO 4412 HEXASTAT CAPS, 50 & 100MG 1981-12-18 Inactive II N/A